vs
INSTEEL INDUSTRIES INC（IIIN）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
INSTEEL INDUSTRIES INC的季度营收约是再鼎医药的1.3倍（$159.9M vs $127.1M），INSTEEL INDUSTRIES INC同比增速更快（23.3% vs 17.1%），INSTEEL INDUSTRIES INC自由现金流更多（$-2.2M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 12.0%）
Insteel Industries Inc是美国领先的钢材加固产品制造商，主营焊接钢筋网、工程结构网、钢纤维等产品，主要服务北美地区非住宅建筑、基础设施、预制混凝土构件等领域客户，提供高性能建筑加固解决方案。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
IIIN vs ZLAB — 直观对比
营收规模更大
IIIN
是对方的1.3倍
$127.1M
营收增速更快
IIIN
高出6.2%
17.1%
自由现金流更多
IIIN
多$24.5M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $159.9M | $127.1M |
| 净利润 | $7.6M | — |
| 毛利率 | 11.3% | 51.0% |
| 营业利润率 | 6.0% | -54.6% |
| 净利率 | 4.7% | — |
| 营收同比 | 23.3% | 17.1% |
| 净利润同比 | 602.4% | — |
| 每股收益（稀释后） | $0.39 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIINZLAB
| Q4 25 | $159.9M | $127.1M | ||
| Q3 25 | $177.4M | $115.4M | ||
| Q2 25 | $179.9M | $109.1M | ||
| Q1 25 | $160.7M | $105.7M | ||
| Q4 24 | $129.7M | $108.5M | ||
| Q3 24 | $134.3M | $101.8M | ||
| Q2 24 | $145.8M | $100.1M | ||
| Q1 24 | $127.4M | $87.1M |
净利润IIINZLAB
| Q4 25 | $7.6M | — | ||
| Q3 25 | $14.6M | $-36.0M | ||
| Q2 25 | $15.2M | $-40.7M | ||
| Q1 25 | $10.2M | $-48.4M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $4.7M | $-41.7M | ||
| Q2 24 | $6.6M | $-80.3M | ||
| Q1 24 | $6.9M | $-53.5M |
毛利率IIINZLAB
| Q4 25 | 11.3% | 51.0% | ||
| Q3 25 | 16.1% | 59.5% | ||
| Q2 25 | 17.1% | 60.6% | ||
| Q1 25 | 15.3% | 63.6% | ||
| Q4 24 | 7.3% | 61.5% | ||
| Q3 24 | 9.1% | 64.1% | ||
| Q2 24 | 10.6% | 64.9% | ||
| Q1 24 | 12.3% | 61.4% |
营业利润率IIINZLAB
| Q4 25 | 6.0% | -54.6% | ||
| Q3 25 | 10.8% | -42.3% | ||
| Q2 25 | 11.0% | -50.3% | ||
| Q1 25 | 8.3% | -53.3% | ||
| Q4 24 | 1.1% | -62.6% | ||
| Q3 24 | 4.5% | -66.6% | ||
| Q2 24 | 6.0% | -76.0% | ||
| Q1 24 | 7.0% | -80.7% |
净利率IIINZLAB
| Q4 25 | 4.7% | — | ||
| Q3 25 | 8.2% | -31.2% | ||
| Q2 25 | 8.4% | -37.3% | ||
| Q1 25 | 6.4% | -45.8% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 3.5% | -40.9% | ||
| Q2 24 | 4.5% | -80.2% | ||
| Q1 24 | 5.4% | -61.4% |
每股收益（稀释后）IIINZLAB
| Q4 25 | $0.39 | $-0.05 | ||
| Q3 25 | $0.74 | $-0.03 | ||
| Q2 25 | $0.78 | $-0.04 | ||
| Q1 25 | $0.52 | $-0.04 | ||
| Q4 24 | $0.06 | $-0.09 | ||
| Q3 24 | $0.24 | $-0.04 | ||
| Q2 24 | $0.34 | $-0.08 | ||
| Q1 24 | $0.35 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.6M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $358.8M | $715.5M |
| 总资产 | $456.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IIINZLAB
| Q4 25 | $15.6M | $689.6M | ||
| Q3 25 | $38.6M | $717.2M | ||
| Q2 25 | $53.7M | $732.2M | ||
| Q1 25 | $28.4M | $757.3M | ||
| Q4 24 | $36.0M | $779.7M | ||
| Q3 24 | $111.5M | $616.1M | ||
| Q2 24 | $97.7M | $630.0M | ||
| Q1 24 | $83.9M | $650.8M |
股东权益IIINZLAB
| Q4 25 | $358.8M | $715.5M | ||
| Q3 25 | $371.5M | $759.9M | ||
| Q2 25 | $356.2M | $791.7M | ||
| Q1 25 | $341.4M | $810.8M | ||
| Q4 24 | $331.6M | $840.9M | ||
| Q3 24 | $350.9M | $667.7M | ||
| Q2 24 | $346.0M | $704.2M | ||
| Q1 24 | $340.6M | $762.2M |
总资产IIINZLAB
| Q4 25 | $456.1M | $1.2B | ||
| Q3 25 | $462.6M | $1.2B | ||
| Q2 25 | $471.9M | $1.2B | ||
| Q1 25 | $421.9M | $1.2B | ||
| Q4 24 | $404.7M | $1.2B | ||
| Q3 24 | $422.6M | $985.3M | ||
| Q2 24 | $414.6M | $987.4M | ||
| Q1 24 | $397.2M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-701.0K | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.2M | $-26.7M |
| 自由现金流率自由现金流/营收 | -1.4% | -21.0% |
| 资本支出强度资本支出/营收 | 0.9% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.09× | — |
| 过去12个月自由现金流最近4个季度 | $439.0K | $-158.9M |
8季度趋势，按日历期对齐
经营现金流IIINZLAB
| Q4 25 | $-701.0K | $-26.0M | ||
| Q3 25 | $-17.0M | $-32.0M | ||
| Q2 25 | $28.5M | $-31.0M | ||
| Q1 25 | $-3.3M | $-61.7M | ||
| Q4 24 | $19.0M | $-55.8M | ||
| Q3 24 | $16.2M | $-26.8M | ||
| Q2 24 | $18.8M | $-42.2M | ||
| Q1 24 | $1.4M | $-90.1M |
自由现金流IIINZLAB
| Q4 25 | $-2.2M | $-26.7M | ||
| Q3 25 | $-18.7M | $-35.0M | ||
| Q2 25 | $26.9M | $-33.9M | ||
| Q1 25 | $-5.5M | $-63.2M | ||
| Q4 24 | $16.3M | $-58.4M | ||
| Q3 24 | $14.5M | $-28.2M | ||
| Q2 24 | $15.5M | $-42.9M | ||
| Q1 24 | $-580.0K | $-91.1M |
自由现金流率IIINZLAB
| Q4 25 | -1.4% | -21.0% | ||
| Q3 25 | -10.6% | -30.4% | ||
| Q2 25 | 15.0% | -31.1% | ||
| Q1 25 | -3.5% | -59.9% | ||
| Q4 24 | 12.6% | -53.8% | ||
| Q3 24 | 10.8% | -27.7% | ||
| Q2 24 | 10.7% | -42.9% | ||
| Q1 24 | -0.5% | -104.5% |
资本支出强度IIINZLAB
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 1.0% | 2.6% | ||
| Q2 25 | 0.9% | 2.6% | ||
| Q1 25 | 1.4% | 1.5% | ||
| Q4 24 | 2.1% | 2.4% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 2.2% | 0.7% | ||
| Q1 24 | 1.5% | 1.1% |
现金转化率IIINZLAB
| Q4 25 | -0.09× | — | ||
| Q3 25 | -1.17× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | -0.32× | — | ||
| Q4 24 | 17.56× | — | ||
| Q3 24 | 3.48× | — | ||
| Q2 24 | 2.86× | — | ||
| Q1 24 | 0.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
